We use cookies to run the site and, with your permission, to measure how it is used. You can accept all of them or deny the ones that are not needed. Read the cookie policy.
Intravenous iron therapy in chronic kidney disease and peritoneal dialysis patients.(Sponsored Educational Supplement): An article from: Nephrology Nursing Journal
⭐ Ratings & Reviews
No reviews yet — be the first!
No reviews yet.
📖 Description
This digital document is an article from Nephrology Nursing Journal, published by Jannetti Publications, Inc. on October 1, 2003. The length of the article is 5057 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
From the author: Identical National Kidney Foundation Kidney Disease Outcomes Quality Initiative (K/DOQI) hematologic and iron targets apply to chronic kidney disease (CKD), peritoneal dialysis (PD), and hemodialysis (HD) patients, yet intravenous (IV) nondextran iron therapy is FDA approved only in HD patients. This is because oral iron has been considered adequate in CKD and PD patients, and delivering a parenteral therapy on a frequent basis to an outpatient population with notoriously poor vascular access presents logistical complexities. However, recognition of the need for more aggressive treatment of anemia in the CKD and PD population is growing. This awareness, along with the improved safety profiles of the new, nondextran irons, is tipping the risk-benefit ratio toward more widespread use of IV iron in these patients. This article provides a summary of the literature and of our own experience using IV iron therapy in CKD and PD patients. Our protocol relies on early monitoring and intervention with IV ferric gluconate before severe iron deficiency develops. The proactive approach allows for relatively infrequent treatments at only moderately "high" doses (250 mg) of ferric gluconate. The convergence of convenience and safety may expedite more energetic anemia prevention and treatment in PD and CKD patients.
Citation Details Title: Intravenous iron therapy in chronic kidney disease and peritoneal dialysis patients.(Sponsored Educational Supplement) Author: Vaughn W. Folkert Publication:Nephrology Nursing Journal (Refereed) Date: October 1, 2003 Publisher: Jannetti Publications, Inc. Volume: 30 Issue: 5 Page: 571(7)
